Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/IL/Rockford
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Rockford, IL

Studies commonly pay $75 to $4,500 per completed study

112 clinical trials are currently recruiting participants within 30 miles of Rockford. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

112studies recruiting
7+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Rockford right now

Top 25 of 112 recruiting studies, sorted by proximity — each links to its official registry page

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 Phase 3 Interventional 1,209 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05946213)

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm Phase 2 Interventional 70 participants sought
Mercyhealth Cancer Institute - Rockford — Rockford, Illinois (1.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06126276)

A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer Phase 2 Interventional 99 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04302025)

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Phase 3 Interventional 364 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT04510597)

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

Paroxysmal Atrial Fibrillation N/A Observational 250 participants sought
Mercy Health — Janesville, Wisconsin (29.3 mi) · Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06324201)

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia Phase 2 Interventional 93 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06672146)

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Phase 2 Interventional 240 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05327686)

Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

Metastatic Digestive System Neuroendocrine Tumor G1, Metastatic Digestive System Neuroendocrine Tumor G2 Phase 2 Interventional 100 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05773274)

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Cardiovascular Risk, Acute Myocardial Infarction (AMI) Phase 3 Interventional 10,000 participants sought
OSF HealthCare_Cardiovasc Inst — Rockford, Illinois (1.7 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT06118281)

Evaluating the Prognostic Capability of ctDNA as a Biomarker in Pancreatic Cancer Patients Undergoing Neoadjuvant Chemotherapy

Pancreas Cancer N/A Observational 500 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: Northwestern University
See eligibility & contact on ClinicalTrials.gov (NCT04616131)

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer Phase 3 Interventional 1,160 participants sought
Research Site — Rockford, Illinois (1.7 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06692738)

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 247 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04269902)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma Phase 2, Phase 3 Interventional 992 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05987241)

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenosquamous Carcinoma Phase 2 Interventional 152 participants sought
Mercyhealth Hospital and Cancer Center - Janesville — Janesville, Wisconsin (29.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04858334)

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma Phase 3 Interventional 360 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05256225)

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 1,100 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06632327)

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma Phase 3 Interventional 336 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07061977)

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Multiple conditions Phase 2 Interventional 150 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05136196)

Effectiveness of an Automated Falls-Risk Screening and Referral Tool in the Emergency Department (ED)

Falls-Risk N/A Observational 30,000 participants sought
Swedish American Emergency Department — Rockford, Illinois (1.7 mi) · Sponsor: University of Wisconsin, Madison
See eligibility & contact on ClinicalTrials.gov (NCT05810064)

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma Phase 2 Interventional 26 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05647265)

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Pancreatic Neoplasm N/A Observational 770 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04239573)

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum N/A Interventional 9,500 participants sought
Mercyhealth Cancer Institute - Rockford — Rockford, Illinois (1.7 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05080673)

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

Glioblastoma, IDH-Wildtype, MGMT-Unmethylated Glioblastoma Phase 3 Interventional 398 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07452458)
Actively enrolling

Studies you may be able to join near Rockford

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Rockford

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

UW Health | Carbone Cancer Center Rockford Laboratory

★ 4.8
3535 N Bell School Rd, Rockford, IL 61114
(779) 696-9400
"Friendly staff knowable staff all appointments right on time Dr Kahn took the time to answer all my questions"
— Fred Amundson, 5★

UW Health | Carbone Cancer Center Rockford

★ 4.7
3535 N Bell School Rd, Rockford, IL 61114
(779) 696-9400
"Nice and easy. On time. The two nurses were very experienced with very pleasant demeanor and helpful attitude."
— waleed said, 5★

Chicago Clinical Research Institute, Inc.

★ 5.0
611 W Roosevelt Rd, Chicago, IL 60607
(312) 823-6800

Innovative Clinical Research Center

★ 2.3
521 Kora Ln, Island Lake, IL 60042
"On March, 11 2024 I had a Urinary tract problem which they asked me to send results to a lab, and getting medication the same day, but that medicatio…"
— Jared Avitia, 1★

Avicenna Clinical Research

★ 4.9
9912 SW Hwy, Oak Lawn, IL 60453
(708) 575-5535
"Joy Jibunoh was very professional and knowledgeable!! Showed great patience when asking questions with clarity!"
— tony torres, 5★

New Life Clinical Research llc

★ 5.0
(847) 454-3872
"I am deeply grateful to Ekta Grewal for her incredible support throughout my journey in the NLCR program. Not only did she provide me with a partial …"
— Brianna Oppong-Antwi, 5★

Pillar Clinical Research, Chicago, Illinois

★ 4.8
3400 N Pulaski Rd, Chicago, IL 60641
(224) 534-7332
"All the staff of GREAT ADMINISTRATION THEY REALLY TAKE CARE OF THEIR PEOLE. AND I DO MEAN ALL. IT WAS A BEAUTIFUL EXPERIENCE. I WOULD DEFINITELY RECO…"
— Vig Dall, 5★

Clinical trials in Rockford: what's recruiting

The Rockford area currently has 112 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Rockford, the most active research areas are:

  • Cancer & Oncology19 studies
  • Liver & Kidney3 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Rockford, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Rockford

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Rockford participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Rockford?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Rockford safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Rockford, IL?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Rockford?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Rockford.

Paid clinical trials near Rockford

Other metros within reach

Madison, WI528 Aurora, IL614 Round Lake Beach, IL465 Naperville, IL2,346 Joliet, IL515 Milwaukee, WI696 Chicago, IL2,431 Peoria, IL218

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Rockford Chronic Kidney Disease (HealthMatch) in Rockford Bladder Issues Due To Spinal Cord Injury in Rockford All conditions

More of IL

Chicago2,431 Naperville2,346 Aurora614 Joliet515 Round Lake Beach465 Peoria218 Springfield182 Champaign170

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts